⌘K

Home/Filings/4/0000950170-25-043942

4//SEC Filing

Apeiron Investment Group Ltd. 4

Accession 0000950170-25-043942

CIK 0001840904other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 5:00 PM ET

Size

6.9 KB

Accession

0000950170-25-043942

Insider Transaction Report

Form 4

Period: 2025-03-24

ATAI Life Sciences N.V.ATAI

Apeiron Investment Group Ltd.

10% Owner

Transactions

Purchase
Common Shares
2025-03-24$1.40/sh+1,800,000$2,520,000→ 42,369,415 total(indirect: By Apeiron Investment Group Ltd.)

Holdings

Common Shares
(indirect: By Apeiron Presight Capital Fund II, L.P.)
1,799,302

Angermayer Christian

Director10% Owner

Transactions

Purchase
Common Shares
2025-03-24$1.40/sh+1,800,000$2,520,000→ 42,369,415 total(indirect: By Apeiron Investment Group Ltd.)

Holdings

Common Shares
(indirect: By Apeiron Presight Capital Fund II, L.P.)
1,799,302

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

IncorporatedMalta

Related Parties

1

filerCIK 0001845711

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 5:00 PM ET
Size: 6.9 KB

View on SEC.gov